Orlando, Florida – HUPO 2018 – (October 1, 2018) Today, at the 17th Human Proteome Organization World Congress, Biognosys and Evosep promote a robust, high-throughput workflow for clinical research proteomics.
(June 4, 2018) Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics.
We are getting a lot of questions about Evosep these days, and we are excited that you want to know who we are and what we do. To answer the most asked question and to share our perspectives on clinical proteomics we have conducted four short blog post for you to read.
It has been a pleasure introducing you to who we are. We hope you know us a little better by now, and will enjoy reading about our future thoughts on mass spectrometry-based omics.
Last time we talked about our view on proteomics right now, and today we are introducing you to the Evosep One – a novel separation solution designed for fast and robust separation of omics samples in large clinical cohort studies (primarily proteomics and metabolomics).
